Methemoglobin in critically ill septic patients-Reference-Cited by-同舟云学术

Methemoglobin in critically ill septic patients

Published:2024-09-13 Issue: Volume: Page:1-8
ISSN:1752-0363
Container-title:Biomarkers in Medicine
language:en
Short-container-title:Biomarkers in Medicine

Author:

Phongphithakchai Atthaphong¹²^ORCID,Maeda Akinori¹,Hikasa Yukiko¹,Spano Sofia¹,Pattamin Nuttapol¹,Chaba Anis¹,Eastwood Glenn¹³⁴,Young Helen¹,Peck Leah¹,Bellomo Rinaldo¹³⁴⁵⁶^ORCID

Affiliation:

1. Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia

2. Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand

3. Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia

4. Australian & New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia

5. Data Analytics Research & Evaluation Centre, Austin Hospital, Melbourne, Australia

6. Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17520363.2024.2395246

Reference27 articles.

1. Sepsis—Pathophysiology and Therapeutic Concepts

2. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study

3. A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach

4. The role of nitric oxide in sepsis - an overview

5. Administration of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)*